38 / 64
242
31.- Carrington C B, Gaensler E A, Coutu R E,
FitzGerald M X, Gupta R G. Natural history and
treated course of usual and desquamative interstitial
pneumonia. N Engl J Med 1978; 298: 801-9.
32.- Ryu J H, Colby T V, Hartman T E, Vassallo
R. Smoking-related interstitial lung diseases: a concise
review. Eur Respir J 2001; 17: 122-132.
33.- Hartman T E, Primack S L, Swensen S J,
Hansell D, McGuinness G, Muller N L.
Desquamative interstitial pneumonia: thin-section CT
findings in 22 patients. Radiology 1993; 187: 787-90.
34.- AkiraM, Yamamoto S, HaraH, Sakatani M,
Ueda E. Serial computed tomographic evaluation in
desquamative interstitial pneumonia. Thorax 1997; 52:
333-7.
35.- Desai S R, Ryan S M, Colby T V. Smoking-related
interstitial lung diseases: histopathological and imaging
perspectives. Clin Radiol 2003; 58: 259-68.
36.- Yousem S A, Colby T V, Gaensler E A. Respi-
ratory bronchiolitis-associated interstitial lung disease
and its relationship to desquamative interstitial pneu-
monia. Mayo Clin Proc 1989; 64: 1373-80.
37.- Katzenstein A-LA, Mukhopadhyay S, Za-
nardi C, Dexter E. Clinically occult interstitial
fibrosis in smokers: classification and significance of a
surprisingly common finding in lobectomy specimens.
Hum Pathol 2010; 41: 316-25.
38.- Katzenstein A-LA. Smoking-related interstitial
fibrosis (SRIF): pathologic findings and distinction
from other chronic fibrosing lung diseases. J Clin Pathol
2013; 66: 882-7.
39.- Yousem S A. Respiratory bronchiolitis-associated
interstitial lung disease with fibrosis is a lesion distinct
from fibrotic nonspecific interstitial pneumonia: a pro-
posal. Mod Pathol 2006; 19: 1474-1479.
40.- El-Kersh K, Pérez R L, Smith J S, Fraig M.
Smoking-related interstitial fibrosis (SRIF) and pul-
monary hypertension. BMJ Case Rep 2013; 2013: doi:
10.1136/bcr-2013-008970.
41.- Reddy T L, Mayo J, Churg A. Respiratory bron-
chiolitis with fibrosis: high-resolution computed tomo-
graphy findings and correlation with pathology. Ann Am
Thorac Soc 2013; 10: 590-601
42.- Katzenstein A L. Smoking-related interstitial
fibrosis (SRIF), pathogenesis and treatment of usual
interstitial pneumonia (UIP), and transbronchial biopsy
in UIP. Mod Pathol 2012; 25(Suppl 1): S68-S78.
43.- Behr J, Günther A, Ammenwerth W,
Bittmann I, Bonnet R, Buhl R, et al. Ger-
man guideline for diagnosis and management of
idiopathic pulmonary fibrosis. Pneumologie 2013;
67: 81-111.
44.- Raghu G, Collard H R, Egan J J, Martínez
F J, Behr J, Brown K K, et al. An official ATS/
ERS/JRS/ALAT statement: idiopathic pulmonary
fibrosis: evidence-based guidelines for diagnosis and
management. Am J Respir Crit Care Med 2011; 183:
788-824.
45.- Uchiyama H, Suda T, Nakamura Y, Shirai
M, Gemma H, Shirai T, et al. Alterations in smoking
habits are associated with acute eosinophilic pneumonia.
Chest 2008; 133: 1174-80.
46.- Rhee C K, Min K H, Yim N Y, Lee J E, Lee N R,
Chung M P, et al. Clinical characteristics and corticos-
teroid treatment of acute eosinophilic pneumonia. Eur
Respir J 2013; 41: 402-9.
47.- Shorr A F, Scoville S L, Cersovsky S B,
Shanks G D, Ockenhouse C F, Smoak B L, et
al. Acute eosinophilic pneumonia among US Military
personnel deployed in or near Iraq. JAMA 2004; 292:
2997-3005.
48.- Mikuls T R, Sayles H, Yu F, Levan T, Gould
K A, Thiele G M, et al. Associations of cigarette
smoking with rheumatoid arthritis in African Americans.
Arthritis Rheum 2010; 62: 3560-8.
49.- Kelly C A, Saravanan V, Nisar M, Artha-
nari S, Woodhead F A, Price-Forbes AN, et
al. Rheumatoid arthritis-related interstitial lung disease:
associations, prognostic factors and physiological and
radiological characteristics-a large multicentre UK
study. Rheumatology (Oxford) 2014; 53: 1676-82.
50.- Hutchinson D, Shepstone L, Moots R, Lear
J T, Lynch M P. Heavy cigarette smoking is strongly
associated with rheumatoid arthritis (RA), particularly
in patients without a family history of RA. Ann Rheum
Dis 2001; 60: 223-7.
51.- Donaghy M, Rees A J. Cigarette smoking and lung
haemorrhage in glomerulonephritis caused by autoanti-
bodies to glomerular basement membrane. Lancet 1983;
2: 1390-3.
52.- Chan A L, Louie S, Leslie K O, Juarez
M M, Albertson T E. Cutting edge issues in
Goodpasture’s disease. Clin Rev Allergy Immunol 2011;
41: 151-62.
53.- Leatherman J W, Davies S F, Hoidal J R. Al-
veolar hemorrhage syndromes: diffuse microvascular
lung hemorrhage in immune and idiopathic disorders.
Medicine (Baltimore) 1984; 63: 343-61.
54.- Inoue Y, Trapnell B C, Tazawa R, Arai T,
Takada T, Hizawa N, et al. Characteristics of a
large cohort of patients with autoimmune pulmonary
alveolar proteinosis in Japan. Am J Respir Crit Care
Med 2008; 177: 752-62.
55.- Tazawa R, Trapnell B C, Inoue Y, Arai T,
TakadaT, NasuharaY, et al. Inhaled granulocyte/
macrophage colony stimulating factor as therapy for
pulmonary alveolar proteinosis. Am J Respir Crit Care
Med 2010; 181: 1345-54.
56.- Bonella F, Bauer P C, Griese M, Ohshimo
S, Guzmán J, Costabel U. Pulmonary alveolar
proteinosis: new insights from a single-center cohort of
70 patients. Respir Med 2011; 105: 1908-16.
A. Pinto S. et al.
Rev Chil Enferm Respir 2016; 32: 233-243